scispace - formally typeset
E

Eugene Maxwell

Researcher at Merck & Co.

Publications -  6
Citations -  619

Eugene Maxwell is an academic researcher from Merck & Co.. The author has contributed to research in topics: Receptor & Protein kinase B. The author has an hindex of 5, co-authored 6 publications receiving 585 citations.

Papers
More filters
Journal Article

Biochemical Characterization of the Binding of Echistatin to Integrin αvβ3 Receptor

TL;DR: It is demonstrated that echistatin binding to α vβ 3 is of high affinity and irreversible similar to vitronectin and provides an alternate ligand for high-throughput screening for α v β 3 antagonists.
Journal ArticleDOI

The Farnesyl Transferase Inhibitor SCH 66336 Induces a G2 → M or G1 Pause in Sensitive Human Tumor Cell Lines

TL;DR: Experiments show that SCH 66336 altered the cell cycle distribution of sensitive human tumor cells in two distinct ways, and suggest that cell cycle effects, either G(1) or G(2)-->M accumulation, and p53 status are important for mediating the effects of FTIs on tumor cells.
Journal Article

Neutralizing Anti-Insulin-like Growth Factor Receptor 1 Antibodies Inhibit Receptor Function and Induce Receptor Degradation in Tumor Cells

TL;DR: neutralizing antibodies against IGFR1 represent a valid approach to inhibit growth of tumor cells and inhibited the growth of MCF7 cells in soft agar.
Journal Article

Adenoviral-mediated expression of a kinase-dead mutant of Akt induces apoptosis selectively in tumor cells and suppresses tumor growth in mice.

TL;DR: In vitro proliferation of human and mouse tumor cells expressing high levels of activated/phosphorylated Akt was inhibited by both Akt-DN and p53, in comparison with control viruses expressing beta-galactosidase and empty virus.